Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002

By E. Tiemersma, S. Bronzwaer, O. Lyytikäinen, J. Degener, P. Schrijnemakers, N. Bruinsma, J. Monen, W. Witte, H. Grundmann. Emerging Infectious Diseases, 2004

630 citations recorded by the source corpus.

European Antimicrobial Resistance Surveillance System shows large variations in methicillin-resistant S. aureus.

Subfields: General Decision Sciences, Marketing, Sociology and Political Science

View Paper: https://www.semanticscholar.org/paper/30b3f14a6457205792e670b490c6249209a40b2d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Voss
2. J. Bakker
3. A. Friedrich
4. C. Klaassen
5. S. Kalenić
6. M. Wulf
7. C. Vink
8. F. Loeffen

Citations in the corpus

• The molecular evolution of methicillin-resistant Staphylococcus aureus. (2007, background): “The low prevalence of MRSA in The Netherlands and Scandinavia has been attributed to a low antibiotic selection pressure and screening of ‘high-risk’ patients for MRSA before or at the time of admission to a hospital (‘search-anddestroy’ policy) [115].”
• Methicillin-resistant Staphylococcus aureus in Pig Farming (2005, background): “In the Netherlands, the prevalence of MRSA among clinical isolates is still <1%, among the lowest in Europe (1).”